Catalytic organometallic anticancer complexes - Dougan, Sarah J; Habtemariam, Abraha; McHale, Sarah E; Parsons, Simon; Sadler, Peter J (Proceedings of the National Academy of Sciences - PNAS, 2008)
Keywords: animal ovaries; antineoplastic agents; Antineoplastic Agents - chemical synthesis; Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacology; aqueous solutions; biphenyl; Cancer; Catalysis; catalysts; Cell Line, Tumor; Cell lines; Cell Survival - drug effects; Cells; Chlorides; Cytotoxicity; Electrochemistry; Fluorescence; glutathione; Glutathione - metabolism; Humans; Hydrolysis; Iodides; Ligands; Metals; Molecular Structure; neoplasm cells; neoplasms; Neoplasms - metabolism; Neoplasms - pathology; Organic chemicals; Organometallic Compounds - chemical synthesis; Organometallic Compounds - chemistry; Organometallic Compounds - pharmacology; organomineral complexes; Oxidation; Oxidation-Reduction; p-cymene; Physical Sciences; Proteins; Reactive oxygen species; Reactive Oxygen Species - metabolism; Redox reactions; reducing agents; Ruthenium; Ruthenium Compounds - chemical synthesis; Ruthenium Compounds - chemistry; Ruthenium Compounds - pharmacology; Structure-Activity Relationship; Toxicity